Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Goldman Sachs told investors to buy Intuitive Surgical shares because robot-assisted procedures will double in the next two years. The firm initiated coverage on the surgical robot maker with a buy rating.
Intuitive Surgical is one of the best-performing stocks in the market this year. The company's shares are up 34 percent year to date compared with the 7 percent return.
"With less than 4 percent of U.S. surgeries employing robotics today, we think investors should own this structural winner as the market doubles in the next few years," analyst Isaac Ro wrote in a note to clients Tuesday. "We think emerging markets are underappreciated and near-term concerns on competition are overblown given ISRG's proven outcomes/ease."
His Intuitive Surgical 12-month price target is $1,000, representing 18 percent upside from Monday's close of $850.67.
Ro predicts robot-assisted procedures will rise by 100 percent in the next two years due to increasing usage during hernia and gall bladder surgeries. He also noted that less than 3 percent of tier-three (facilities with more than 500 beds) hospitals in China have an Intuitive Surgical robot system.
"As the Tier 3 hospital market in China is the same size as the entire U.S. hospital market, we think the long-term opportunity to expand the installed base in China is significant and underappreciated," he wrote.
As a result, Ro estimates Intuitive Surgical will generate earnings per share of $23.87 in 2017 and $27.30 in 2018 compared with the Wall Street consensus of $23.60 and $27.08, respectively.
"We see new product cycles, an expanding platform, high hurdles for physician training, and significant financial resources as tail winds to ISRG's competitive position," the analyst wrote.
— CNBC's Michael Bloom contributed to this story.